The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia
Open accessAbstract
Graphical abstract Figure. No Caption available. Abstract Diabetes increases the risk and worsens the progression of cognitive impairment via the greater occurrence of small vessel disease and stroke. Yet, the underlying mechanisms are not fully understood. It is now accepted that cardiovascular health is critical for brain health and any neurorestorative approaches to prevent/delay cognitive deficits should target the conceptual neurovascular unit (NVU) rather than neurons alone. We have recently shown that there is augmented hippocampal NVU remodeling after a remote ischemic injury in diabetes. NLRP3 inflammasome signaling has been implicated in the development of diabetes and neurodegenerative diseases, but little is known about the impact of NLRP3 activation on functional and structural interaction within the NVU of hippocampus, a critical part of the brain that is involved in forming, organizing, and storing memories. Endothelial cells are at the center of the NVU and produce trophic factors such as brain derived neurotrophic factor (BDNF) contributing to neuronal survival, known as vasotrophic coupling. Therefore, the aims of this study focused on two hypotheses: 1) diabetes negatively impacts hippocampal NVU remodeling and worsens cognitive outcome after stroke, and 2) NLRP3 inhibition with MCC950 will improve NVU remodeling and cognitive outcome following stroke via vasotrophic (un)coupling between endothelial cells and hippocampal neurons. Stroke was induced through a 90‐min transient middle cerebral artery occlusion (MCAO) in control and high‐fat diet/streptozotocin‐induced (HFD/STZ) diabetic male Wistar rats. Saline or MCC950 (3 mg/kg), an inhibitor of NLRP3, was injected at 1 and 3 h after reperfusion. Cognition was assessed over time and neuronal density, blood‐brain barrier (BBB) permeability as well as NVU remodeling (aquaporin‐4 [AQP4] polarity) was measured on day 14 after stroke. BDNF was measured in endothelial and hippocampal neuronal cultures under hypoxic and diabetes‐mimicking condition with and without NLRP3 inhibition. Diabetes increased neuronal degeneration and BBB permeability, disrupted AQP4 polarity, impaired cognitive function and amplified NLRP3 activation after ischemia. Inhibition with MCC950 improved cognitive function and vascular integrity after stroke in diabetic animals and prevented hypoxia‐mediated decrease in BDNF secretion. These results are the first to provide essential data showing MCC950 has the potential to become a therapeutic to prevent neurovascular remodeling and worsened cognitive decline in diabetic patients following stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Interplay between Cortical Spreading Depolarization and Seizures
Kramer, D. R., Fujii, T., Ohiorhenuan, I., & Liu, C. Y. (2017) · Stereotactic and Functional Neurosurgery · doi:10.1159/000452841 · Cited by 3,696
An Energy Budget for Signaling in the Grey Matter of the Brain
Attwell, D., & Laughlin, S. B. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00001 · Cited by 3,543
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Mechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · cited 1×
“NLRP3 is the most widely studied inflammasome and has been implicated in the development of diabetes [15,16,24–26] and neurodegenerative diseases [27,28], including stroke [29,30].”
Regulation of inflammasome activation
Man, S. M., & Kanneganti, T. (2015) · Immunological Reviews · doi:10.1111/imr.12296 · Cited by 1,064
Diabetes and cognitive dysfunction
McCrimmon, R. J., Ryan, C. M., & Frier, B. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60360-2 · Cited by 880
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Lee, H.-M., Kim, J.-J., Kim, H. J., Shong, M., Ku, B. J., & Jo, E.-K. (2013) · Diabetes · doi:10.2337/db12-0420 · Cited by 734
Tyler, W. J., Alonso, M., Bramham, C. R., & Pozzo-Miller, L. D. (2002) · Learning & Memory · doi:10.1101/lm.51202 · Cited by 682
Walsh, J. G., Muruve, D. A., & Power, C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3638 · Cited by 637
Morrison, H. W., & Filosa, J. A. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-4 · Cited by 506
Self-citationNLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke
Yang, F., Wang, Z., Wei, X., Han, H., Meng, X., Zhang, Y., Shi, W., Li, F., Xin, T., Pang, Q., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.242 · Cited by 422
Gorelick, P. B., Furie, K. L., Iadecola, C., Smith, E. E., Waddy, S. P., Lloyd-Jones, D. M., Bae, H.-J., Bauman, M. A., Dichgans, M., Duncan, P. W., et al. (2017) · Stroke · doi:10.1161/str.0000000000000148 · Cited by 411
Jourdan, T., Godlewski, G., Cinar, R., Bertola, A., Szanda, G., Liu, J., Tam, J., Han, T., Mukhopadhyay, B., Skarulis, M. C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3265 · Cited by 388
Microglia mediate postoperative hippocampal inflammation and cognitive decline in mice
Feng, X., Valdearcos, M., Uchida, Y., Lutrin, D., Maze, M., & Koliwad, S. K. (2017) · JCI Insight · doi:10.1172/jci.insight.91229 · Cited by 361
Bekinschtein, P., Cammarota, M., & Medina, J. H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.024 · Cited by 349
van der Heijden, T., Kritikou, E., Venema, W., van Duijn, J., van Santbrink, P. J., Slütter, B., Foks, A. C., Bot, I., & Kuiper, J. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309575 · Cited by 348
Pathophysiology of the Neurovascular Unit: Disease Cause or Consequence?
Stanimirovic, D. B., & Friedman, A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.25 · Cited by 346
van Hout, G. P. J., Bosch, L., Ellenbroek, G. H. J. M., de Haan, J. J., van Solinge, W. W., Cooper, M. A., Arslan, F., de Jager, S. C. A., Robertson, A. A. B., Pasterkamp, G., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw247 · Cited by 331
Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
D’Adamo, E., & Caprio, S. (2011) · Diabetes Care · doi:10.2337/dc11-s212 · Cited by 315
Expression of the NLRP3 Inflammasome in Cerebral Cortex After Traumatic Brain Injury in a Rat Model
Liu, H.-D., Li, W., Chen, Z.-R., Hu, Y.-C., Zhang, D.-D., Shen, W., Zhou, M.-L., Zhu, L., & Hang, C.-H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1115-z · Cited by 274
Self-citationNeuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons
Guo, S., Kim, W. J., Lok, J., Lee, S.-R., Besancon, E., Luo, B.-H., Stins, M. F., Wang, X., Dedhar, S., & Lo, E. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801105105 · Cited by 253
Clinical presentations and epidemiology of vascular dementia
Smith, E. E. (2017) · Clinical Science · doi:10.1042/cs20160607 · Cited by 249
Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions.
Hempstead, B. L. (2015) · Europe PMC (PubMed Central) · Cited by 247
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
Amantea, D., Micieli, G., Tassorelli, C., Cuartero, M. I., Ballesteros, I., Certo, M., Moro, M. A., Lizasoain, I., & Bagetta, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00147 · Cited by 216
Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke
Scott, J. F., Robinson, G. M., French, J. M., O'Connell, J. E., Alberti, K., & Gray, C. S. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74948-5 · Cited by 208
Sex differences in quality of life after ischemic stroke
Bushnell, C. D., Reeves, M. J., Zhao, X., Pan, W., Prvu-Bettger, J., Zimmer, L., Olson, D., & Peterson, E. (2014) · Neurology · doi:10.1212/wnl.0000000000000208 · Cited by 191
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
Zhou, K., Shi, L., Wang, Y., Chen, S., & Zhang, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/9238290 · Cited by 178
Ismael, S., Nasoohi, S., & Ishrat, T. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5344 · Cited by 171
Mohamed, I., Hafez, S. S., Fairaq, A., Ergul, A., Imig, J. D., & El‐Remessy, A. B. (2013) · Diabetologia · doi:10.1007/s00125-013-3101-z · Cited by 166
Self-citationNLRP3 inflammasome activation is associated with proliferative diabetic retinopathy
Loukovaara, S., Piippo, N., Kinnunen, K., Hytti, M., Kaarniranta, K., & Kauppinen, A. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13427 · Cited by 162
Intermittent fasting attenuates inflammasome activity in ischemic stroke
Fann, D. Y., Santro, T., Manzanero, S., Widiapradja, A., Cheng, Y., Lee, S.-Y., Chunduri, P., Jo, D., Stranahan, A. M., Mattson, M. P., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.017 · Cited by 160
Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke
Hayakawa, K., Qiu, J., & Lo, E. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05728.x · Cited by 153
Inhibiting the Inflammasome: A Chemical Perspective
Baldwin, A. G., Brough, D., & Freeman, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01091 · Cited by 148
Gall, S., Tran, P. L., Martin, K. L., Blizzard, L., & Srikanth, V. K. (2012) · Stroke · doi:10.1161/strokeaha.111.632547 · Cited by 147
Cellular Mechanisms of Neurovascular Damage and Repair After Stroke
Arai, K., Lok, J. M., Guo, S., Hayakawa, K., Xing, C., & Lo, E. H. (2011) · Journal of Child Neurology · doi:10.1177/0883073811408610 · Cited by 135
Shi, H., Zhang, Z., Wang, X., Li, R., Hou, W., Bi, W., & Zhang, X. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.060 · Cited by 132
Prakash, R., Li, W., Qu, Z. X., Johnson, M., Fagan, S. C., & Ergul, A. (2013) · Stroke · doi:10.1161/strokeaha.113.001660 · Cited by 120
Self-citationTranslational models for vascular cognitive impairment: a review including larger species
Hainsworth, A. H., Allan, S. M., Boltze, J., Cunningham, C. J., Farris, C. W., Head, E., Ihara, M., Isaacs, J. D., Kalaria, R. N., Oberstein, S. A. J. L., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0793-9 · Cited by 111
Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes
Prakash, R., Johnson, M. H., Fagan, S. C., & Ergul, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056264 · Cited by 95
Self-citationDiabetes, aging, and cognitive decline
Ryan, C. M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.006 · Cited by 95
Impact of Metabolic Diseases on Cerebral Circulation: Structural and Functional Consequences
Coucha, M. M., Abdelsaid, M. A., Ward, R., Abdul, Y., & Ergul, A. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170019 · Cited by 95
Self-citationMizui, T., Ishikawa, Y., Kumanogoh, H., & Kojima, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.019 · Cited by 88
Morrison, H. W., & Filosa, J. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.047 · Cited by 85
Self-citationThakkar, R., Wang, R., Sareddy, G. R., Wang, J., Thiruvaiyaru, D. S., Vadlamudi, R. K., Zhang, Q., & Brann, D. W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8309031 · Cited by 84
Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice
Hong, P., Li, F., Gu, R., Fang, Y., Lai, L., Wang, Y., Tao, T., Xu, S., You, Z.-J., & Zhang, H. (2018) · Neural Plasticity · doi:10.1155/2018/9163521 · Cited by 74
Abdelsaid, M. A., Prakash, R., Li, W., Coucha, M. M., Hafez, S. S., Johnson, M. H., Fagan, S. C., & Ergul, A. (2014) · Diabetes · doi:10.2337/db14-1423 · Cited by 73
Self-citationAT1 Receptor Antagonism Is Proangiogenic in the Brain: BDNF a Novel Mediator
Alhusban, A., Kozak, A., Ergul, A., & Fagan, S. C. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197483 · Cited by 71
Self-citationIshrat, T., Pillai, B. A., Soliman, S. M., Fouda, A. Y., Kozak, A., Johnson, M. H., Ergul, A., & Fagan, S. C. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8830-6 · Cited by 69
Self-citationContinuous rise in incidence of childhood Type 1 diabetes in Germany
Ehehalt, S., Blumenstock, G., Willasch, A. M., Hub, R., Ranke, M. B., Neu, A., & for the DIARY‐study Group Baden‐Württemberg (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02450.x · Cited by 68
Dolunay, A., Şenol, Ş. P., Temiz-Reşitoğlu, M., Güden, D. S., Sari, A. N., Şahan-Fırat, S., & Tunçtan, B. (2016) · Inflammation · doi:10.1007/s10753-016-0483-3 · Cited by 64
Delayed neuronal death and damage of GDNF family receptors in CA1 following focal cerebral ischemia
Wang, W., Redecker, C., Bidmon, H. J., & Witte, O. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.034 · Cited by 62
Kumar, P., Krishna, P., Reddy, S. C., Gurappa, M., Aravind, S. R., & Munichoodappa, C. (2008) · PubMed · Cited by 59
Bushnell, C., & McCullough, L. D. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0762 · Cited by 53
Ward, R., Valenzuela, J. P., Li, W., Dong, G., Fagan, S. C., & Ergul, A. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00390.2018 · Cited by 53
Self-citationNLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
Klen, J., Goričar, K., Janež, A., & Dolžan, V. (2015) · Journal of Diabetes Research · doi:10.1155/2015/616747 · Cited by 52
Guan, J., Tong, W., Ding, W., Du, S., Xiao, Z., Han, Q., Zhu, Z., Bao, X., Shi, X., Wu, C., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.073 · Cited by 51
Fouda, A. Y., Alhusban, A., Ishrat, T., Pillai, B. A., Eldahshan, W., Waller, J. L., Ergul, A., & Fagan, S. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9675-3 · Cited by 45
Self-citationRelationship of endothelin-1 and NLRP3 inflammasome activation in HT22 hippocampal cells in diabetes
Ward, R., & Ergul, A. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.043 · Cited by 42
Self-citationGender difference in diabetes-associated risk of first-ever and recurrent ischemic stroke
Policardo, L., Seghieri, G., Francesconi, P., Anichini, R., Franconi, F., Seghieri, C., & Prato, S. D. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.008 · Cited by 38
Diabetes Mellitus and Disturbances in Brain Connectivity: A Bidirectional Relationship?
Mansur, R. B., Cha, D. S., Woldeyohannes, H. O., Soczynska, J. K., Zugman, A., Brietzke, E. M., & McIntyre, R. S. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8316-8 · Cited by 30
What Does Local Functional Hyperemia Tell about Local Neuronal Activation?
Jukovskaya, N., Tiret, P., Lecoq, J. A., & Charpak, S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3146-10.2011 · Cited by 30
Li, W., Ward, R., Valenzuela, J. P., Dong, G., Fagan, S. C., & Ergul, A. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0525-7 · Cited by 29
Self-citationDai, X., Okon, I. S., Liu, Z., Bédarida, T., Wang, Q., Ramprasath, T., Zhang, M., Song, P., & Zou, M. (2017) · Diabetes · doi:10.2337/db17-0132 · Cited by 29
Microglial activation during acute cerebral infarction in the presence of diabetes mellitus
Li, G., Xu, X.-Y., Wang, D., Wang, J., Wang, Y., & Yu, J. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0632-2 · Cited by 23
Madsen, T. E., Khoury, J. C., Alwell, K., Moomaw, C. J., Demel, S. L., Flaherty, M. L., Woo, D., Mackey, J. S., Rosa, F. D. L. R. L., Martini, S. R., et al. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12567 · Cited by 19
Ward, R., Abdul, Y., & Ergul, A. (2018) · Physiological Research · doi:10.33549/physiolres.933837 · Cited by 12
Self-citation
Cited by
NLRP3 and pyroptosis blockers for treating inflammatory diseases
Coll, R. C., Schroder, K., & Pelegrín, P. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.04.003 · Cited by 755
NLRP3 inflammasome in endothelial dysfunction
Bai, B., Yang, Y., Wang, Q., Li, M., Tian, C., Liu, Y., Aung, L. H. H., Li, P.-F., Yu, T., & Chu, X.-M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02985-x · Cited by 491
Więckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101397 · Cited by 343
“…by diabetes, insulin induced hypoglycemia and proved to be alleviated by diet manipulation through alternate-day fasting (Abdul et al., 2020; Deng et al., 2014; Ward et al., 2019; Zhang et al., 2017), indicating that WD feeding can also affect AD progression via changes in astrocyte AQP4 polarity.”
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Xu, W., Huang, Y., & Zhou, R. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01275-w · Cited by 295
Chen, H., He, Y., Chen, S., Qi, S., & Shen, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104877 · Cited by 282
Metadata
- Authors
- Ward, R., Li, W., Abdul, Y., Jackson, L., Dong, G., Jamil, S., Filosa, J., Fagan, S. C., & Ergul, A.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 142
- Pages
- 237-250
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2915252464
- Cited by
- 270
- References
- 76
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.